Vivifi Medical的动态

Being the founder of a Medtech Startup in a complex world of healthcare innovation requires more than Innovative ideas. Preparedness can be the difference between success and failure. Build an organization that can weather the storm and be ready to seize opportunities that may lie ahead! #medicaldevices?#startup?#medtech?#projectmedtech?#innovation?#medicaldevice?#podcast?#strategy

Following the recent news of Laplace Interventional announcing the successful first in human (FIH) procedure in early feasibility study of its transcatheter tricuspid valve replacement device...we release the MedTech Startup Podcast (or Vidcast?): Ramji Iyer, Founder and CEO of Laplace Interventional?and Giovanni Lauricella, Managing Partner of Lifeblood , sat down in St. Paul, Minnesota at a brewery to discuss what it takes to start a Class III heart valve technology from scratch and inject turbo energy into taking it from a concept to a thriving company! Check out this recent article on FIH data: https://lnkd.in/gqpPN8hE Ramji shares his journey and experiences as a MedTech entrepreneur. He discusses his early interest in engineering, the importance of mentors, his transition from corporate life to the startup world, and the exciting growth of Laplace Interventional. Ramji also offers his insights into fundraising challenges and strategies, the value of execution in a startup environment, and the importance of showing progress to potential investors. This conversation provides valuable insights for anyone interested in the entrepreneurial side of the MedTech industry. 00:00 Introduction and Background 00:37 Interview with Ramji Iyer, CEO of Laplace Interventional 01:15 Ramji's Journey: From India to CEO of a Medtech Startup 03:12 The Birth and Growth of Laplace Interventional 06:05 The Role of a CEO in a Medtech Startup 12:47 The Fundraising Journey of Laplace Interventional 20:16 Dealing with Institutional Investors 21:13 Convincing Investors and Showing Progress 22:14 Developing Investor Relationships 22:50 Understanding Fundraising Mechanics 24:15 Challenges of Series A and Series B 25:08 The Appeal of the Twin Cities 27:03 The Current State of Heart Valve Innovation 29:37 Handling Rejection in Fundraising 31:06 Advice for Future Entrepreneurs 33:04 The Story Behind the Company Name 33:31 Closing Remarks Hope ya'll enjoy what Ramji Iyer has to say, and take notes on what it looks like to build, fund, and achieve FIH data with rapid speed! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

Following the recent news of Laplace Interventional announcing the successful first in human (FIH) procedure in early feasibility study of its transcatheter tricuspid valve replacement device...we release the MedTech Startup Podcast (or Vidcast?): Ramji Iyer, Founder and CEO of Laplace Interventional?and Giovanni Lauricella, Managing Partner of Lifeblood , sat down in St. Paul, Minnesota at a brewery to discuss what it takes to start a Class III heart valve technology from scratch and inject turbo energy into taking it from a concept to a thriving company! Check out this recent article on FIH data: https://lnkd.in/gqpPN8hE Ramji shares his journey and experiences as a MedTech entrepreneur. He discusses his early interest in engineering, the importance of mentors, his transition from corporate life to the startup world, and the exciting growth of Laplace Interventional. Ramji also offers his insights into fundraising challenges and strategies, the value of execution in a startup environment, and the importance of showing progress to potential investors. This conversation provides valuable insights for anyone interested in the entrepreneurial side of the MedTech industry. 00:00 Introduction and Background 00:37 Interview with Ramji Iyer, CEO of Laplace Interventional 01:15 Ramji's Journey: From India to CEO of a Medtech Startup 03:12 The Birth and Growth of Laplace Interventional 06:05 The Role of a CEO in a Medtech Startup 12:47 The Fundraising Journey of Laplace Interventional 20:16 Dealing with Institutional Investors 21:13 Convincing Investors and Showing Progress 22:14 Developing Investor Relationships 22:50 Understanding Fundraising Mechanics 24:15 Challenges of Series A and Series B 25:08 The Appeal of the Twin Cities 27:03 The Current State of Heart Valve Innovation 29:37 Handling Rejection in Fundraising 31:06 Advice for Future Entrepreneurs 33:04 The Story Behind the Company Name 33:31 Closing Remarks Hope ya'll enjoy what Ramji Iyer has to say, and take notes on what it looks like to build, fund, and achieve FIH data with rapid speed! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

Following the recent news of Laplace Interventional announcing the successful first in human (FIH) procedure in early feasibility study of its transcatheter tricuspid valve replacement device...we release the MedTech Startup Podcast (or Vidcast?): Ramji Iyer, Founder and CEO of Laplace Interventional?and Giovanni Lauricella, Managing Partner of Lifeblood , sat down in St. Paul, Minnesota at a brewery to discuss what it takes to start a Class III heart valve technology from scratch and inject turbo energy into taking it from a concept to a thriving company! Check out this recent article on FIH data: https://lnkd.in/ekyPsmtC Ramji shares his journey and experiences as a MedTech entrepreneur. He discusses his early interest in engineering, the importance of mentors, his transition from corporate life to the startup world, and the exciting growth of Laplace Interventional. Ramji also offers his insights into fundraising challenges and strategies, the value of execution in a startup environment, and the importance of showing progress to potential investors. This conversation provides valuable insights for anyone interested in the entrepreneurial side of the MedTech industry. 00:00 Introduction and Background 00:37 Interview with Ramji Iyer, CEO of Laplace Interventional 01:15 Ramji's Journey: From India to CEO of a Medtech Startup 03:12 The Birth and Growth of Laplace Interventional 06:05 The Role of a CEO in a Medtech Startup 12:47 The Fundraising Journey of Laplace Interventional 20:16 Dealing with Institutional Investors 21:13 Convincing Investors and Showing Progress 22:14 Developing Investor Relationships 22:50 Understanding Fundraising Mechanics 24:15 Challenges of Series A and Series B 25:08 The Appeal of the Twin Cities 27:03 The Current State of Heart Valve Innovation 29:37 Handling Rejection in Fundraising 31:06 Advice for Future Entrepreneurs 33:04 The Story Behind the Company Name 33:31 Closing Remarks Hope ya'll enjoy what Ramji Iyer has to say, and take notes on what it looks like to build, fund, and achieve FIH data with rapid speed! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

Following the recent news of Laplace Interventional announcing the successful first in human (FIH) procedure in early feasibility study of its transcatheter tricuspid valve replacement device...we release the MedTech Startup Podcast (or Vidcast?): Ramji Iyer, Founder and CEO of Laplace Interventional?and Giovanni Lauricella, Managing Partner of Lifeblood , sat down in St. Paul, Minnesota at a brewery to discuss what it takes to start a Class III heart valve technology from scratch and inject turbo energy into taking it from a concept to a thriving company! Check out this recent article on FIH data: https://lnkd.in/gqpPN8hE Ramji shares his journey and experiences as a MedTech entrepreneur. He discusses his early interest in engineering, the importance of mentors, his transition from corporate life to the startup world, and the exciting growth of Laplace Interventional. Ramji also offers his insights into fundraising challenges and strategies, the value of execution in a startup environment, and the importance of showing progress to potential investors. This conversation provides valuable insights for anyone interested in the entrepreneurial side of the MedTech industry. 00:00 Introduction and Background 00:37 Interview with Ramji Iyer, CEO of Laplace Interventional 01:15 Ramji's Journey: From India to CEO of a Medtech Startup 03:12 The Birth and Growth of Laplace Interventional 06:05 The Role of a CEO in a Medtech Startup 12:47 The Fundraising Journey of Laplace Interventional 20:16 Dealing with Institutional Investors 21:13 Convincing Investors and Showing Progress 22:14 Developing Investor Relationships 22:50 Understanding Fundraising Mechanics 24:15 Challenges of Series A and Series B 25:08 The Appeal of the Twin Cities 27:03 The Current State of Heart Valve Innovation 29:37 Handling Rejection in Fundraising 31:06 Advice for Future Entrepreneurs 33:04 The Story Behind the Company Name 33:31 Closing Remarks Hope ya'll enjoy what Ramji Iyer has to say, and take notes on what it looks like to build, fund, and achieve FIH data with rapid speed! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

Innovation and Leadership in Technology with Nash Sichon on "Gaining the Technology Leadership Edge" In the latest episode of our podcast, Nash Sichon shares invaluable insights from his journey as a co-founder of Sci Spot and his experience at Y Combinator, the prestigious startup accelerator. Here are some key highlights: 1. Starting with Scrappiness (04:03): Nash emphasizes the Y Combinator mantra of building a product's "scrappiest version" to test market viability. This approach is essential for rapid pivots and refining business hypotheses based on real user feedback. 2. Cutting Down Drug Development Time (01:07): At Sci Spot, Nash and his team leveraged their combined expertise in biotechnology and tech to automate 40-45% of drug development workflows, significantly reducing the time it takes to bring new drugs to market—from 15 years to about eight. 3. The Y Combinator Impact (02:08): Nash describes his time at Y Combinator as transformative, shifting vital business questioning from subconscious routines to deliberate strategies that ensure product-market fit and user-centric development. 4. Embracing Technological Change (09:30): A tech industry veteran, Nash advocates embracing change as a constant, highlighting that adaptability and continuous learning are crucial for technology leaders and their teams. Nash's journey underscores the powerful intersection of technology, innovation, and strategic business practices. If his story resonates with you or you're keen to share your experiences and insights as a technology leader, we would love to feature you on our show. ?? Connect and Collaborate: Send the word "PODCAST" to us directly to discuss being a guest on future episodes. Let's dive into the evolving world of technology leadership together! #TechnologyLeadership #Innovation #Startups #YCombinator #PodcastGuests

In this week's podcast episode, we are excited to welcome Doug Nissinoff, Managing Director and Founder at Intelligence Ventures as well as Principal and Founder at Renegade BioConsulting. Intelligence Ventures emerged as a pioneering venture capital firm, dedicated to propelling innovation at the nexus of artificial intelligence and healthcare within the United States. Their focal point lies in strategically investing and nurturing pre-seed, seed, and Series A companies, fostering their growth and shaping the future of the industry. With their debut fund, AI Health Fund I, Intelligence Ventures targets companies utilising AI to address complex challenges in drug development, clinical trials, and patient care, transcending industry boundaries to advance innovation in biotech, pharma, medtech, and diagnostics. Renegade BioConsulting, a global executive consultancy, specialises in international expansion, corporate communications, fundraising, and commercialization for companies within the Biotech, Pharma, and MedTech sectors. With a client-centric approach, they prioritise tailored solutions, ensuring successful outcomes and rapid turnaround times. ?? Episode Highlights: Join us in this insightful conversation as he shares his career trajectory and experience in the intersection of healthcare and AI. ?? What to Expect: - An analysis of the current state of VC and activities in the healthcare and AI industries - The significance of AI in the healthcare sector - Investment strategies of Intelligent Ventures - Differences between the US and European investment markets - The role of VC firms - The importance of Secondary investments ?? Start listening: You can listen to the podcast either through our podcast home page or at Spotify (links in the comments). More channels are added as well! Get ready for an episode filled with insights into the world of AI and healthcare in venture capital.

Following the recent news of Laplace Interventional announcing the successful first in human (FIH) procedure in early feasibility study of its transcatheter tricuspid valve replacement device...we release the MedTech Startup Podcast (or Vidcast?): Ramji Iyer, Founder and CEO of Laplace Interventional?and Giovanni Lauricella, Managing Partner of Lifeblood , sat down in St. Paul, Minnesota at a brewery to discuss what it takes to start a Class III heart valve technology from scratch and inject turbo energy into taking it from a concept to a thriving company! Check out this recent article on FIH data: https://lnkd.in/gqpPN8hE Ramji shares his journey and experiences as a MedTech entrepreneur. He discusses his early interest in engineering, the importance of mentors, his transition from corporate life to the startup world, and the exciting growth of Laplace Interventional. Ramji also offers his insights into fundraising challenges and strategies, the value of execution in a startup environment, and the importance of showing progress to potential investors. This conversation provides valuable insights for anyone interested in the entrepreneurial side of the MedTech industry. 00:00 Introduction and Background 00:37 Interview with Ramji Iyer, CEO of Laplace Interventional 01:15 Ramji's Journey: From India to CEO of a Medtech Startup 03:12 The Birth and Growth of Laplace Interventional 06:05 The Role of a CEO in a Medtech Startup 12:47 The Fundraising Journey of Laplace Interventional 20:16 Dealing with Institutional Investors 21:13 Convincing Investors and Showing Progress 22:14 Developing Investor Relationships 22:50 Understanding Fundraising Mechanics 24:15 Challenges of Series A and Series B 25:08 The Appeal of the Twin Cities 27:03 The Current State of Heart Valve Innovation 29:37 Handling Rejection in Fundraising 31:06 Advice for Future Entrepreneurs 33:04 The Story Behind the Company Name 33:31 Closing Remarks Hope ya'll enjoy what Ramji Iyer has to say, and take notes on what it looks like to build, fund, and achieve FIH data with rapid speed! With love for shaking MedTech insights loose from good humans and sharing them with the community, Mister MedTech P.S. Come on ya'll...like and subscribe to the MedTech Startup YouTube channel here: https://lnkd.in/e6Quni7z ...

In this episode, serial entrepreneur Dr. Mahmood Razavi and our host Dr. Bryan Hartley discuss factors to consider when starting a medical technology company, steps of the innovation process, and fundraising strategies. The startup process requires entrepreneurs to recruit team members and raise funds. Dr. Razavi uses equity as a recruiting tool to bring business and engineering experts into the company. He also describes various methods of funding, including venture capital and strategic partnerships and the pros and cons of each. Listen here: https://ow.ly/tKgW50QsQyF #Startup #PhysicianEntrepreneur #MedTech #VentureCapital

The next 36 months will be a transformative period for AI and investments in this space. History rhymes. Just as startup investments from 2008-11 defined the winners of the last cycle, investments made in this 3-year AI-driven Innovation Supercycle will define the leaders in this space. I enjoyed my conversation with Jason Calacanis, David Weisburd and Bryan Rosenblatt on the Liquidity Podcast. We discussed current opportunities in AI and why, given the unprecedented revenue growth of today’s startups, early-stage rounds may be the only access most investors get. Watch the clip below and access the full episode on YouTube. https://lnkd.in/g96QGAtG #InnovationSuperCycle #VentureCapital #Artificialintelligence #VCInsights #TechInvesting #EarlyStageInvesting